Dilip Shanghvi serves as the Managing Director of Sun Pharmaceutical Industries Limited. He was the founder (1983) of Sun Pharmaceutical Industries Ltd., which became the largest pharmaceutical company in India and one of the largest generic-drug producers in the world. In 1983, he founded Sun Pharmaceutical Industries, focusing initially on psychiatric drugs. The company began with a single manufacturing facility in Vapi, Gujarat. Dilip studied at JJ Ajmera High School and graduated with a bachelor’s degree in commerce from Bhawanipur Education Society College, University of Calcutta.

Under his leadership, the company grew rapidly through organic expansion and strategic acquisitions, becoming a global pharmaceutical powerhouse with a presence in over 100 countries. Today, Sun Pharma is the fourth largest specialty generic pharmaceutical company in the world with global revenues of US $5.4 billion.

Beyond his business achievements, he is a former President of Indian Pharmaceutical Alliance (IPA) and has also served as the chairman of the Board of Governors of Indian Institute of Technology (Bombay). He is a trustee of the Rhodes Scholarship Program at Oxford University. A first-generation entrepreneur, Mr. Shanghvi has won numerous awards and recognitions, including Forbes’s Entrepreneur of the Year Award (2014).  Indiaspora is proud to have Dilip Shanghvi on our Business Leaders 2.0 List.